Eser, A. Et Al. 2016. Efficacy and safety of eltrombopag in treatment-refractory primary immune thrombocytopenia: a retrospective study.. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis , vol.27, no.1 , 47-52.

Eser, A., Toptas, T., Kara, O., Sezgin, A., Noyan-Atalay, F., Yilmaz, G., ... Ozgumus, T.(2016). Efficacy and safety of eltrombopag in treatment-refractory primary immune thrombocytopenia: a retrospective study.. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis , vol.27, no.1, 47-52.

Eser, Ali Et Al. "Efficacy and safety of eltrombopag in treatment-refractory primary immune thrombocytopenia: a retrospective study.," Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis , vol.27, no.1, 47-52, 2016

Eser, Ali Et Al. "Efficacy and safety of eltrombopag in treatment-refractory primary immune thrombocytopenia: a retrospective study.." Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis , vol.27, no.1, pp.47-52, 2016

Eser, A. Et Al. (2016) . "Efficacy and safety of eltrombopag in treatment-refractory primary immune thrombocytopenia: a retrospective study.." Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis , vol.27, no.1, pp.47-52.

@article{article, author={Ali Eser Et Al. }, title={Efficacy and safety of eltrombopag in treatment-refractory primary immune thrombocytopenia: a retrospective study.}, journal={Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis}, year=2016, pages={47-52} }